The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation
- PMID: 17179479
- DOI: 10.1093/jnci/djj495
The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation
Abstract
Background: If cancer arises and is maintained by a small population of cancer-initiating cells within every tumor, understanding how these cells react to cancer treatment will facilitate improvement of cancer treatment in the future. Cancer-initiating cells can now be prospectively isolated from breast cancer cell lines and tumor samples and propagated as mammospheres in vitro under serum-free conditions.
Methods: CD24(-/low)/CD44+ cancer-initiating cells were isolated from MCF-7 and MDA-MB-231 breast cancer monolayer cultures and propagated as mammospheres. Their response to radiation was investigated by assaying clonogenic survival and by measuring reactive oxygen species (ROS) levels, phosphorylation of the replacement histone H2AX, CD44 levels, CD24 levels, and Notch-1 activation using flow cytometry. All statistical tests were two-sided.
Results: Cancer-initiating cells were more resistant to radiation than cells grown as monolayer cultures (MCF-7: monolayer cultures, mean surviving fraction at 2 Gy [SF(2Gy)] = 0.2, versus mammospheres, mean SF(2Gy) = 0.46, difference = 0.26, 95% confidence interval [CI] = 0.05 to 0.47; P = .026; MDA-MB-231: monolayer cultures, mean SF(2Gy) = 0.5, versus mammospheres, mean SF(2Gy) = 0.69, difference = 0.19, 95% CI = -0.07 to 0.45; P = .09). Levels of ROS increased in both mammospheres and monolayer cultures after irradiation with a single dose of 10 Gy but were lower in mammospheres than in monolayer cultures (MCF-7 monolayer cultures: 0 Gy, mean = 1.0, versus 10 Gy, mean = 3.32, difference = 2.32, 95% CI = 0.67 to 3.98; P = .026; mammospheres: 0 Gy, mean = 0.58, versus 10 Gy, mean = 1.46, difference = 0.88, 95% CI = 0.20 to 1.56; P = .031); phosphorylation of H2AX increased in irradiated monolayer cultures, but no change was observed in mammospheres. Fractionated doses of irradiation increased activation of Notch-1 (untreated, mean = 10.7, versus treated, mean = 15.1, difference = 4.4, 95% CI = 2.7 to 6.1, P = .002) and the percentage of the cancer stem/initiating cells in the nonadherent cell population of MCF-7 monolayer cultures (untreated, mean = 3.52%, versus treated, mean = 7.5%, difference = 3.98%, 95% CI = 1.67% to 6.25%, P = .009).
Conclusions: Breast cancer-initiating cells are a relatively radioresistant subpopulation of breast cancer cells and increase in numbers after short courses of fractionated irradiation. These findings offer a possible mechanism for the accelerated repopulation of tumor cells observed during gaps in radiotherapy.
Comment in
-
Cancer stem cells and radiotherapy: new insights into tumor radioresistance.J Natl Cancer Inst. 2006 Dec 20;98(24):1755-7. doi: 10.1093/jnci/djj505. J Natl Cancer Inst. 2006. PMID: 17179471 No abstract available.
Similar articles
-
Senescence evasion by MCF-7 human breast tumor-initiating cells.Breast Cancer Res. 2010;12(3):R31. doi: 10.1186/bcr2583. Epub 2010 Jun 2. Breast Cancer Res. 2010. PMID: 20525204 Free PMC article.
-
STAT1 promotes radioresistance of CD44(+)/CD24(-/low) cells in breast cancer.Exp Biol Med (Maywood). 2011 Apr 1;236(4):418-22. doi: 10.1258/ebm.2011.010287. Epub 2011 Mar 28. Exp Biol Med (Maywood). 2011. PMID: 21444368
-
A monoclonal antibody against human Notch1 ligand-binding domain depletes subpopulation of putative breast cancer stem-like cells.Mol Cancer Ther. 2012 Jan;11(1):77-86. doi: 10.1158/1535-7163.MCT-11-0508. Epub 2011 Nov 10. Mol Cancer Ther. 2012. PMID: 22075160
-
Mammary stem cells and breast cancer--role of Notch signalling.Stem Cell Rev. 2007 Jun;3(2):169-75. doi: 10.1007/s12015-007-0023-5. Stem Cell Rev. 2007. PMID: 17873349 Review.
-
Triterpene Acid (3-O-p-Coumaroyltormentic Acid) Isolated From Aronia Extracts Inhibits Breast Cancer Stem Cell Formation through Downregulation of c-Myc Protein.Int J Mol Sci. 2018 Aug 26;19(9):2528. doi: 10.3390/ijms19092528. Int J Mol Sci. 2018. PMID: 30149665 Free PMC article. Review.
Cited by
-
A promising target for breast cancer: B7-H3.BMC Cancer. 2024 Feb 7;24(1):182. doi: 10.1186/s12885-024-11933-3. BMC Cancer. 2024. PMID: 38326735 Free PMC article. Review.
-
A novel approach for transforming breast cancer stem cells into endothelial cells.Exp Ther Med. 2023 Dec 21;27(2):74. doi: 10.3892/etm.2023.12362. eCollection 2024 Feb. Exp Ther Med. 2023. PMID: 38264426 Free PMC article.
-
Role of the mechanical microenvironment on CD-44 expression of breast adenocarcinoma in response to radiotherapy.Sci Rep. 2024 Jan 3;14(1):391. doi: 10.1038/s41598-023-50473-x. Sci Rep. 2024. PMID: 38172135 Free PMC article.
-
Soloxolone methyl induces apoptosis and oxidative/ER stress in breast cancer cells and target cancer stem cell population.Turk J Biol. 2023 Jun 5;47(4):247-261. doi: 10.55730/1300-0152.2660. eCollection 2023. Turk J Biol. 2023. PMID: 38152618 Free PMC article.
-
Opportunities in Cancer Therapies: Deciphering the Role of Cancer Stem Cells in Tumour Repopulation.Int J Mol Sci. 2023 Dec 8;24(24):17258. doi: 10.3390/ijms242417258. Int J Mol Sci. 2023. PMID: 38139085 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
